Picard Medical shares are trading higher. The company announced completion of acute in vivo implant study series using its next-gen Emperor Total Artificial Heart Platform.

Benzinga Newsdesk www.benzinga.com Positive 69.9%

Neg 0% Neu 0% Pos 69.9%

Comments

No comments yet. Be the first!